-
According to this medication standard, the OS of patients with adjuvant chemotherapy after colon cancer surgery can be significantly prolonged
Time of Update: 2023-01-05
A recent study published in BMC Cancer evaluated the effect of dose intensity on overall survival (OS) in patients undergoing high-risk stage 2 and 3 colon cancer resection in patients receiving adjuvant dual chemotherapy with FOLFOX (5-fluorouracil plus oxaliplatin and folic acid) or CAPROX (capecitabine and oxaliplatin).
-
The researchers found treatment options for patients with blood cancers who relapsed after CAR-T treatment
Time of Update: 2022-11-14
2022017848 Researchers at the Icahn School of Medicine at Mount Sinai and Memorial Sloan-Kettering Cancer Center in the United States have identified therapies that promise to help patients with relapsed multiple myeloma.
-
The number of consumers of betel nut, a first-class carcinogen, has exceeded 100 million, and be wary that these first-level carcinogens are hidden around you
Time of Update: 2022-09-30
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
Does chewing betel nuts cause oral cancer?
The rigorous answer from doctors is that betel nut is a risk factor for oral cancer.
-
Combination drug therapy in mice can block drug resistance and stop tumor growth
Time of Update: 2022-09-06
Image credit: Simone Hausmann and Pawel MazurAccording to a study in mice conducted by researchers at Washington University School of Medicine in St. Louis, the University of the Alpes in Grenoble, France, and the MD Anderson Cancer Center at the University of Texas in Houston, experimental combinations of the two drugs could stop the development of small cell lung cancer, the deadliest form of lung cancer.
-
Researchers discover new factor predicting breast cancer recurrence
Time of Update: 2022-05-14
Researchers at the Georgetown Lombardi Comprehensive Cancer Center have discovered that genes and other factors can predict whether women are at risk for breast cancer recurrence, opening up new research possibilities to prevent the development of new tumors .
-
Immunotherapy drug holds promise for advanced endometrial cancer
Time of Update: 2022-01-24
For the study, researchers recruited 90 women diagnosed with recurrent or advanced endometrial cancer to determine whether the drug pembrolizumab (marketed as Keytruda) could be an effective treatment for this type of MMR deficiency (dMMR).
-
The team of Professor Ye Dingwei from the Cancer Hospital of Fudan University and the team of Professor Huang Haojie from Mayo Clinic in the United States have discovered potential new targets
Time of Update: 2021-11-16
For many years, the Multidisciplinary Urology and Oncology (MDT) team of Fudan University Cancer Hospital, led by the chief expert Professor Ye Dingwei, has addressed the "three dilemmas" of the low early diagnosis rate of Chinese prostate cancer, the low late survival rate and the lack of effective precision treatment models.
-
860 studies analyze that these eating habits really increase the risk of cancer
Time of Update: 2021-10-23
The study showed that drinking alcohol is associated with increased risk of breast, colorectal, esophageal, head and neck cancer, and liver cancer after menopause; dairy products, pure milk, calcium, and whole grains are associated with a reduced risk of colorectal cancer; coffee drinking is associated with liver cancer It is associated with a reduced risk of skin basal cell carcinoma .
-
Guided ultrasound to deliver drugs to metastatic brain lesions in breast cancer patients｜《Science·Translational Medicine
Time of Update: 2021-10-21
Click on the blue text above to follow our study of four Her2-positive breast cancer patients with brain metastases.
Low-dose MRgFUS temporarily increases the permeability of the blood-brain barrier and can be precisely positioned to open up treatment areas, such as the brain stem, cranial nucleus, and cerebellum, which are not always suitable for surgery or radiation therapy .
-
Putting a "new weapon" on the oncolytic virus to treat pancreatic cancer shows a higher effect
Time of Update: 2021-10-02
▲The virus design structure of TILT-452 (picture source: reference [2])In the pancreatic cancer hamster model, the tumors in the animals treated with TILT-452 shrank significantly, and at the end of the experiment (160 days later), 62.
-
Nat Commun: Cross-ethnic genome-wide association meta-analysis to identify breast cancer risk sites
Time of Update: 2021-08-01
Breast cancerPrevious studies have shown that genome-wide association studies ( GWAS ) have successfully identified about 200 genetic mutation risk sites with low penetrance that are common in the disease .
-
Will the injection of paclitaxel in breast cancer patients affect menstruation
Time of Update: 2021-08-01
m3u8">"Metz Live Class: 3-Day Breast Cancer Diagnosis and Treatment Training Camp" 06.
25-The treatment points and fertility management of young breast cancer.
May I ask, Will paclitaxel affect menstruation?Breast cancer diagnosis and treatment management Likes, comments, and shares are welcomeLeave a message here
-
The death of academician Kong Xiangfu has long been engaged in functional genomics research
Time of Update: 2021-02-24
, June 17 (Xinhua) -- Kong Xiangfu, a non-partisan, academician of the Chinese Academy of Sciences and professor at the Chinese People's Liberation Army Army Military Medical University, died in Chongqing at 11:10 p.m. on June 17, 2019 at the age of 76.
-
The molecular characteristics of liver metastasis in pancreatic cancer were deciphered
Time of Update: 2021-01-22
The prior clinical practice of Sun Yongwei's team confirmed that for patients with highly selected liver oligarch metastatic pancreatic cancer with primary tumors located at the tail of the pancreas, the same-term surgery of primary and metastatic lesions can significantly benefit the survival of patients, with a median survival of up to 16.8 months.
-
Nature Sub-Journal: A liquid biopsy can accurately detect early renal cancer
Time of Update: 2020-07-19
the study, published in the June 22 issue of the journal Nature Medicine, points out that if validated and widely used in larger scale trials, this noninvasive test can detect more undifferentiated early renal cell carcinoma, thereby reducing the mortality of the disease.
